Safety, Effectiveness and Immunogenicity of Heterologous Mrna-1273 Boost after Prime with Ad26.COV2.S among Healthcare Workers in South Africa: the Single-Arm, Open-Label, Phase 3 SHERPA Study Nigel Garrett , Tarylee Reddy , Nonhlanhla Yende-Zuma , Azwidhwi Takalani , Kubashni Woeber , Annie Bodenstein , Phumeza Jonas , Imke Engelbrecht , Waasila Jassat , Harry Moultrie , Debbie Bradshaw , Ishen Seocharan , Jackline Odhiambo , Kentse Khuto , Simone I Richardson , Millicent A Omondi , Rofhiwa Nesamari , Roanne S Keeton , Catherine Riou , Thandeka Moyo-Gwete , Craig Innes , Zwelethu Zwane , Kathy Mngadi , William Brumskine , Nivashnee Naicker , Disebo Potloane , Sharlaa Badal-Faesen , Steve Innes , Shaun Barnabas , Johan Lombaard , Katherine Gill , Maphoshane Nchabeleng , Elizma Snyman , Friedrich Petrick , Elizabeth Spooner , Logashvari Naidoo , Dishiki Kalonji , Vimla Naicker , Nishanta Singh , Rebone Maboa , Pamela Mda , Daniel Malan , Anusha Nana , Mookho Malahleha , Philip Kotze , Jon J Allagappen , Andreas H Diacon , Gertruida M Kruger , Faeezah Patel , Penny L Moore , Wendy A Burgers , Kate Anteyi , Brett Leav , Linda-Gail Bekker , Glenda E Gray , Ameena Goga , SHERPA study team medRxiv (Cold Spring Harbor Laboratory)（2024）
AI 理解论文
溯源树
样例
